Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Serina Therapeutics (SER) Shares Issued (2018 - 2025)

Historic Shares Issued for Serina Therapeutics (SER) over the last 7 years, with Q3 2025 value amounting to $8000.0.

  • Serina Therapeutics' Shares Issued changed N/A to $8000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $10000.0, marking a year-over-year decrease of 9979.95%. This contributed to the annual value of $5.0 million for FY2024, which is 3315333.33% up from last year.
  • According to the latest figures from Q3 2025, Serina Therapeutics' Shares Issued is $8000.0.
  • In the past 5 years, Serina Therapeutics' Shares Issued ranged from a high of $5.0 million in Q2 2024 and a low of -$4.9 million during Q2 2025
  • For the 4-year period, Serina Therapeutics' Shares Issued averaged around $786857.1, with its median value being $14000.0 (2023).
  • Over the last 5 years, Serina Therapeutics' Shares Issued had its largest YoY gain of 12280000.0% in 2025, and its largest YoY loss of 19859.55% in 2025.
  • Serina Therapeutics' Shares Issued (Quarter) stood at $496000.0 in 2021, then plummeted by 97.18% to $14000.0 in 2023, then soared by 35500.0% to $5.0 million in 2024, then tumbled by 99.84% to $8000.0 in 2025.
  • Its Shares Issued stands at $8000.0 for Q3 2025, versus -$4.9 million for Q2 2025 and $4.9 million for Q1 2025.